Foley special counsel John Strom is speaking in the Association for Accessible Medicine’s GRx+Biosims 2024 conference in a panel titled “Legal Overview of the BIOSECURE Act” on October 21.
This panel will provide an overview of the BIOSECURE Act and steps that manufacturers may need to take to ensure compliance. Panelists will provide an overview of the law, its mechanics, and how it applies in the context of government contracts.
People
Related Insights
18 February 2025
DEA Delays Final Buprenorphine Rule
The Department of Health and Human Services and the Drug Enforcement Administration have delayed the effective date of the final rule regarding telemedicine prescribing of buprenorphine to March 21, 2025, and have requested public comments on the rule.
17 February 2025
Foley Viewpoints
6 Steps to Manage Tariff Risks in a Trade War
As Trump seeks to raise U.S. tariffs (which currently tend to be among the lowest worldwide), manufacturers, distributors, retailers, and other companies that frequently import must determine the best strategy to deal with the resulting uncertainties.
25 February 2025
Events
Navigating Tariffs and Supply Chain Contracts: Mitigating Financial and Legal Risks
Join Foley and Lardner LLP partners Greg Husisian, Leah Imbrogno, and Vanessa Miller on Tuesday, February 25, for a Strafford CLE webinar, “Navigating Tariffs and Supply Chain Contracts: Mitigating Financial and Legal Risks.”